The international vaccine development and distribution organization Gavi announced this week that it had committed $50 million to responding to the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC), $40 million of which would go to building up supply chains in preparation of mass production of an Ebola Bundibugyo vaccine.
Gavi, formerly known as the Global Alliance for Vaccines and Immunization, is a coalition that raises funds from public and private actors and serves as a platform for the development of new vaccines and the expansion of access to established vaccines all around the world, with a focus on vulnerable and…
Read the full article at BREITBART.COM
